Paid Clinical Trials in Peoria, AZ
As of August 2026, 36 paid clinical trials are recruiting in Peoria, Arizona. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Peoria offers studies at sites including Arizona Center for Cancer Care-Peoria for conditions such as Rheumatoid Arthritis, Head and Neck Squamous Cell Carcinoma, MASH - Metabolic Dysfunction-Associated Steatohepatitis, Metabolic Dysfunction-Associated Steatotic Liver Disease. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Peoria
Trials by drug in Peoria
Filter results
Newly added in Peoria
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Participants With Obesity and Cardiovascular Risk Factors
34 clinical trials
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
RA-PRO PRAGMATIC TRIAL
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Top Research Study Locations in Peoria
Researchers run research studies in Peoria, AZ at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Arizona Center for Cancer Care-Peoria | Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8, Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Arizona Liver Health - Peoria | MASH - Metabolic Dysfunction-Associated Steatohepatitis, Metabolic Dysfunction-associated Steatohepatitis | 2 |
| Onyx Clinical Research | Crohn's Disease, Ulcerative Colitis | 2 |
| The Institute for Liver Health II DBA Arizona Clinical Trials | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 2 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis | 1 |
| Academic Urology and Urogynecology of Arizona | Prostate Cancer (Adenocarcinoma), Prostate Cancer Patients Treated by Radiotherapy | 1 |
| Altimmune Clinical Study Site | Alcohol Liver Disease | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Arizona Liver Health | MASLD, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis) | 1 |
| Arrowhead North Surgery Center | Lumbar Spinal Stenosis | 1 |
| Associated Retina Consultants - Peoria - DocTrials - PPDS | Diabetic Macular Edema | 1 |
| Associated Retina Consultants - Peoria | Geographic Atrophy | 1 |
| Banner Surgery Center - Peoria | Lumbar Spinal Stenosis | 1 |
| Onyx Clinical Research | Acute Gout Flare, Acute Gouty Arthritis, Gout Flare | 1 |
| Onyx Clinical Research - Peoria | Atopic Dermatitis | 1 |
| Onyx Clinical Research-Peoria | Osteoarthritis, Knee | 1 |
| Onyx Clinical Trials | Focal Epilepsy | 1 |
| Pa0019 114 | Axial Spondyloarthritis, Psoriatic Arthritis | 1 |
| Palo Verde Pain Specialists ASC | Lumbar Spinal Stenosis | 1 |
| Peoria | Endometriosis, Uterine Fibroids | 1 |
| Peoria Foot and Ankle Spclsts | Lumbar Spinal Stenosis | 1 |
| Phoenix Medical Group | COPD | 1 |
| Phoenix Medical Group, PC | Cataplexy, EDS, Fatigue | 1 |
| Sun Valley Arthritis Center | Rheumatoid Arthritis | 1 |
Active & Upcoming Studies in Peoria (2026)
Recruiting trials in Peoria grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Diabetes & metabolic (5 active studies)
- A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin · Phase 3 · AstraZeneca
- A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Participants With Obesity and Cardiovascular Risk Factors · Phase 2 · BioAge Labs, Inc.
Cancer & tumors (4 active studies)
- A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec · Phase 2 · Candel Therapeutics, Inc.
- Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer · Phase 3 · NRG Oncology
Neurology & pain (1 active study)
- Long-term Safety and Tolerability of BHV-7000 · Phase 2 · Biohaven Therapeutics Ltd.
Cardiovascular (1 active study)
Eye & vision (1 active study)
Common conditions studied in Peoria
- Rheumatoid Arthritis (3 active studies)
- Head and Neck Squamous Cell Carcinoma (2 active studies)
- MASH - Metabolic Dysfunction-Associated Steatohepatitis (2 active studies)
- Metabolic Dysfunction-Associated Steatotic Liver Disease (2 active studies)
- Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 (2 active studies)
- Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 (2 active studies)
Leading research sponsors in Peoria
- AstraZeneca
- Sanofi
- Akero Therapeutics, Inc
- Boehringer Ingelheim
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Peoria?
There are approximately 36 recruiting clinical trials in Peoria, Arizona listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Peoria pay participants?
Most recruiting trials in Peoria compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Peoria?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Peoria?
The most common conditions under active study in Peoria include Rheumatoid Arthritis (3), Head and Neck Squamous Cell Carcinoma (2), MASH - Metabolic Dysfunction-Associated Steatohepatitis (2), Metabolic Dysfunction-Associated Steatotic Liver Disease (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Peoria?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Peoria on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Peoria?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Peoria?
Recruiting research sites in Peoria include Arizona Center for Cancer Care-Peoria, Akero Clinical Study Site, Arizona Liver Health - Peoria, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Peoria right now?
The largest active categories in Peoria are Diabetes & metabolic (5), Cancer & tumors (4), Neurology & pain (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.